Effects of priming injections of MDMA and cocaine on reinstatement of MDMA- and cocaine-seeking in rats.

[1]  D. Mash,et al.  MDMA self‐administration in rats: acquisition, progressive ratio responding and serotonin transporter binding , 2007, The European journal of neuroscience.

[2]  G. Rebec,et al.  Reinstatement of MDMA (ecstasy) seeking by exposure to discrete drug-conditioned cues , 2007, Pharmacology Biochemistry and Behavior.

[3]  T. Robbins,et al.  Enduring Deficits in Sustained Visual Attention during Withdrawal of Intravenous Methylenedioxymethamphetamine Self-Administration in Rats: Results from a Comparative Study with d-Amphetamine and Methamphetamine , 2007, Neuropsychopharmacology.

[4]  Serge H. Ahmed,et al.  Heroin-Induced Reinstatement is Specific to Compulsive Heroin Use and Dissociable from Heroin Reward and Sensitization , 2007, Neuropsychopharmacology.

[5]  E. Pehek,et al.  Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. , 2007, Pharmacology & therapeutics.

[6]  Scott E Lukas,et al.  Incidence and patterns of polydrug use and craving for ecstasy in regular ecstasy users: an ecological momentary assessment study. , 2006, Drug and alcohol dependence.

[7]  D. Gittings,et al.  Conditioning following repeated exposure to MDMA in rats: role in the maintenance of MDMA self-administration. , 2006, Behavioral neuroscience.

[8]  L. Baker,et al.  Reinforcement schedule effects in rats trained to discriminate 3,4-methylenedioxymethamphetamine (MDMA) or cocaine , 2006, Psychopharmacology.

[9]  J. Fisk,et al.  Users' perceptions of the risks and effects of taking ecstasy (MDMA): a questionnaire study , 2006, Journal of psychopharmacology.

[10]  M. Morgan,et al.  The sub-acute effects of recreational ecstasy (MDMA) use: a controlled study in humans , 2006, Journal of psychopharmacology.

[11]  U. McCann,et al.  Pharmacokinetic Profile of Single and Repeated Oral Doses of MDMA in Squirrel Monkeys: Relationship to Lasting Effects on Brain Serotonin Neurons , 2006, Neuropsychopharmacology.

[12]  M. Tancer,et al.  Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans trained to discriminate among d-amphetamine, meta-chlorophenylpiperazine and placebo. , 2006, Drug and alcohol dependence.

[13]  A. Swann,et al.  Chronic exposure to MDMA (Ecstasy) elicits behavioral sensitization in rats but fails to induce cross-sensitization to other psychostimulants. , 2006, Behavioral and brain functions : BBF.

[14]  B. Goñi-Allo,et al.  Administration of SCH 23390 into the Medial Prefrontal Cortex Blocks the Expression of MDMA-Induced Behavioral Sensitization in Rats: An Effect Mediated by 5-HT2C Receptor Stimulation and not by D1 Receptor Blockade , 2005, Neuropsychopharmacology.

[15]  S. M. Anderson,et al.  Cocaine-induced alterations in dopamine receptor signaling: implications for reinforcement and reinstatement. , 2005, Pharmacology & therapeutics.

[16]  M. Nader,et al.  A comparison of the reinforcing efficacy of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") with cocaine in rhesus monkeys. , 2005, Drug and alcohol dependence.

[17]  B. Kelly.  Conceptions of Risk in the Lives of Club Drug-Using Youth , 2005, Substance use & misuse.

[18]  B. Goñi-Allo,et al.  Studies on the role of dopamine D1 receptors in the development and expression of MDMA-induced behavioral sensitization in rats , 2004, Psychopharmacology.

[19]  Alex Gamma.  Keeping a clear head on effects of illicit drugs , 2004, Nature.

[20]  R. Glennon,et al.  Comparison of the discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) and cocaine: asymmetric generalization. , 2004, Drug and alcohol dependence.

[21]  D. Gittings,et al.  Effect of SCH 23390 on (±)-3,4-methylenedioxymethamphetamine hyperactivity and self-administration in rats , 2004, Pharmacology Biochemistry and Behavior.

[22]  D. Gittings,et al.  Effects of SCH 23390 and eticlopride on cocaine-seeking produced by cocaine and WIN 35,428 in rats , 2003, Psychopharmacology.

[23]  D. Gittings,et al.  Development, maintenance and temporal pattern of self-administration maintained by ecstasy (MDMA) in rats , 2003, Psychopharmacology.

[24]  H. Sumnall,et al.  The content of ecstasy tablets: implications for the study of their long-term effects. , 2002, Addiction.

[25]  T. Ullrich,et al.  3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement , 2002, Psychopharmacology.

[26]  Y. Shaham,et al.  Neurobiology of Relapse to Heroin and Cocaine Seeking: A Review , 2002, Pharmacological Reviews.

[27]  W. Compton,et al.  Ecstasy abuse and dependence among adolescents and young adults: applicability and reliability of DSM‐IV criteria , 2001, Human psychopharmacology.

[28]  J. Neisewander,et al.  Serotonin depletion attenuates cocaine seeking but enhances sucrose seeking and the effects of cocaine priming on reinstatement of cocaine seeking in rats , 2001, Psychopharmacology.

[29]  A. Winstock,et al.  Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK. , 2001, Drug and alcohol dependence.

[30]  Susan Schenk,et al.  Influence of a conditioned light stimulus on cocaine self-administration in rats , 2001, Psychopharmacology.

[31]  A. Saria,et al.  Reinforcing Effects of MDMA (‘Ecstasy’) in Drug-Naive and Cocaine-Trained Rats , 2001, Pharmacology.

[32]  S. Schenk,et al.  Cocaine-seeking produced by experimenter-administered drug injections: dose-effect relationships in rats , 1999, Psychopharmacology.

[33]  K. Cunningham,et al.  Pharmacological studies of the acute and chronic effects of (+)-3, 4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/1D) receptors. , 1999, The Journal of pharmacology and experimental therapeutics.

[34]  S. Schenk,et al.  Context-Independent Sensitization to the Locomotor-Activating Effects of Cocaine , 1999, Pharmacology Biochemistry and Behavior.

[35]  N. Solowij,et al.  Ecstasy use in Australia: patterns of use and associated harm. , 1999, Drug and alcohol dependence.

[36]  M. Colado,et al.  The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA (`ecstasy') , 1998, Neuropharmacology.

[37]  P. Kalivas,et al.  MDMA Elicits Behavioral and Neurochemical Sensitization in Rats , 1998, Neuropsychopharmacology.

[38]  J. Richards,et al.  Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part I: Synaptosomal uptake and tissue concentrations. , 1996, The Journal of pharmacology and experimental therapeutics.

[39]  J. Richards,et al.  Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part II: Radioligand binding and autoradiography studies. , 1996, The Journal of pharmacology and experimental therapeutics.

[40]  J L Katz,et al.  Serotonergic recovery after (+/-)3,4-(methylenedioxy) methamphetamine injury: observations in rats. , 1993, The Journal of pharmacology and experimental therapeutics.

[41]  J. Brodkin,et al.  Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dopamine release: effect of dopamine uptake inhibitors. , 1991, The Journal of pharmacology and experimental therapeutics.

[42]  R. Peltier,et al.  Supersensitivity to the reinforcing effects of cocaine following 6-hydroxydopamine lesions to the medial prefrontal cortex in rats , 1991, Brain Research.

[43]  C. J. Schmidt,et al.  Direct central effects of acute methylenedioxymethamphetamine on serotonergic neurons. , 1988, European journal of pharmacology.

[44]  C. J. Schmidt,et al.  Depression of rat brain tryptophan hydroxylase activity following the acute administration of methylenedioxymethamphetamine. , 1987, Biochemical pharmacology.

[45]  M. P. Johnson,et al.  Effects of the enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices. , 1986, European journal of pharmacology.

[46]  L. Harris,et al.  Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeys. , 1986, Drug and alcohol dependence.

[47]  R. Stretch,et al.  Drug-induced reinstatement of extinguished self-administration behavior in monkeys , 1975, Pharmacology Biochemistry and Behavior.

[48]  R. Stretch,et al.  Drug-induced reinstatement of amphetamine self-administration behaviour in monkeys. , 1973, Canadian journal of psychology.

[49]  S. Schenk,et al.  Initial deficit and recovery of function after MDMA preexposure in rats , 2005, Psychopharmacology.

[50]  R. D. L. Garza,et al.  Relevance of rodent models of intravenous MDMA self-administration to human MDMA consumption patterns , 2005, Psychopharmacology.

[51]  R. Griffiths,et al.  Self-injection of d,1-3,4-methylenedioxymethamphetamine (MDMA) in the baboon , 2004, Psychopharmacology.

[52]  G. Koob,et al.  MDMA produces stimulant-like conditioned locomotor activity , 2004, Psychopharmacology.

[53]  P. Fletcher,et al.  Reinstatement of alcohol-seeking by priming injections of alcohol and exposure to stress in rats , 1998, Psychopharmacology.

[54]  C. J. Schmidt,et al.  Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. , 1987, The Journal of pharmacology and experimental therapeutics.